✦ LIBER ✦

Long-term safety of ustekinumab in patients with moderate to severe psoriasis through up to 5 years of continuous follow-up

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety of ustekinumab in patie

✍ Papp, K.A.; Griffiths, C.E.M.; Gordon, K.; Lebwohl, M.; Szapary, P.O.; Wasfi, Y. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Long-term efficacy of ustekinumab in pat

✍ A.B. Kimball; K.B. Gordon; S. Fakharzadeh; N. Yeilding; P.O. Szapary; B. Schenke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB

Long-term efficacy of ustekinumab in pat

✍ Kimball, A.B.; Papp, K.A.; Wasfi, Y.; Chan, D.; Bissonnette, R.; Sofen, H.; Yeil 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

Long-term safety of ustekinumab: 5 years

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Malignancies in the ustekinumab psoriasi

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Infections in the ustekinumab psoriasis

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB